Amgen (AMGN) Revenue — Quarter Ended Mar 31, 2024
Revenue declined from the prior quarter but rose compared to the same quarter last year. The sequential decrease followed a strong prior period, while the year-over-year gain continued an upward trend.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q1
Revenue declined from the prior quarter but rose compared to the same quarter last year. The sequential decrease followed a strong prior period, while the year-over-year gain continued an upward trend.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$7.4B
Revenue reported for this quarter.
Quarter-over-quarter
-9.1%
Change from the immediately preceding quarter.
Year-over-year
+22.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$29.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $7B | +5.9% |
| Sep 30, 2023 | $6.9B | +3.8% |
| Dec 31, 2023 | $8.2B | +19.8% |
| Mar 31, 2024 | $7.4B | +22.0% |
Revenue performance
The reported revenue moved lower from the immediately preceding quarter. This reversal came after a period of sequential growth.
Quarterly comparison
Compared with the same quarter one year earlier, revenue was higher. The year-over-year increase was consistent with the prior quarter's annual comparison.
What to watch
The sequential decline in revenue may warrant attention given the prior upward trajectory.